AU2020101758A4 - Preparation Method and Application of Total Flavonoids of Choerospondias Axillaris Leaf - Google Patents

Preparation Method and Application of Total Flavonoids of Choerospondias Axillaris Leaf Download PDF

Info

Publication number
AU2020101758A4
AU2020101758A4 AU2020101758A AU2020101758A AU2020101758A4 AU 2020101758 A4 AU2020101758 A4 AU 2020101758A4 AU 2020101758 A AU2020101758 A AU 2020101758A AU 2020101758 A AU2020101758 A AU 2020101758A AU 2020101758 A4 AU2020101758 A4 AU 2020101758A4
Authority
AU
Australia
Prior art keywords
choerospondias axillaris
leaf
total flavonoids
choerospondias
flavonoids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2020101758A
Inventor
Dongdong ZHAO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baotou Medical College of Inner Mongolia University of Science and Technology
Original Assignee
Baotou Medical College of Inner Mongolia University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baotou Medical College of Inner Mongolia University of Science and Technology filed Critical Baotou Medical College of Inner Mongolia University of Science and Technology
Priority to AU2020101758A priority Critical patent/AU2020101758A4/en
Application granted granted Critical
Publication of AU2020101758A4 publication Critical patent/AU2020101758A4/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/22Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/35Extraction with lipophilic solvents, e.g. Hexane or petrol ether
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/37Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07GCOMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G3/00Glycosides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07GCOMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G5/00Alkaloids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a preparation method and application of total flavonoids extracted from leaves of Choerospondias Axillaris. Extract the leaves of Choerospondias Axillaris with ethanol, and extract and separate the extract with petroleum ether to obtain the total flavonoids of Choerospondias Axillaris Leaf; After ethyl acetate extraction and polyamide column purification, anthocyanins, flavones, flavonols, dihydroflavones, dihydroflavonols, chalcones, isoflavones, flavanols and other flavonoids are separated on silica thin-layer plate. The total flavonoids of Choerospondias Axillaris Leaf have obvious function of anti-arrhythmia, protecting myocardial ischemia, improving immune function, anti-oxidation, etc., and can be used to prepare drugs that can prevent and treat cardiovascular and cerebrovascular diseases, diseases with reduced immune function, and free radical damage diseases. -115 0506 0 0.700 0530 400450.0 6600550. 0IM W L Waveleuth:A94.7 Abs:IJ. 0 1 Figure1I

Description

0506 0
0.700
0530
400450.0 6600550. 0IM WL
Waveleuth:A94.7 Abs:IJ. 0 1
Figure1I
AUSTRALIA
PATENTS ACT 1990
PATENT SPECIFICATION FOR THE INVENTION ENTITLED:
Preparation Method and Application of Total Flavonoids of Choerospondias
Axillaris Leaf
The invention is described in the following statement: -
Preparation Method and Application of Total Flavonoids of Choerospondias
Axillaris Leaf
TECHNICAL FIELD
The present invention relates to the extraction of total flavonoids isolated from the
leaves of Choerospondias Axillaris (Roxb.) Burttet Hill and the process for its preparation
and use in the field of pharmaceutical health products, in particular to application in that
preparation of product for preventing and treatment of cardiovascular and cerebrovascular
diseases, diseases with reduced immune function and disease related to free radical
damage, which belongs to the field of natural medicine chemistry research.
BACKGROUND
Tibetan and Mongolian medicine, as a component of national medicine, has always
been an important part of China's medical treasure-house. The development of Mongolian
medicine has absorbed the essence of Tibetan and Han ethnic medicine, which has been
organically integrated into a whole in long-term practice. With continuous improvement,
modem Mongolian medicine is improving daily and has formed a complete theoretical
system with distinctive national characteristics and categories of modem Mongolian
Medicine with rich clinical experience. It can be said that it has gone through many
vicissitudes and not declined for a long time, which has shown great vitality and potential
value and function.
Choerospondias Axillaris Fructus (the fructus of Choerospondias Axillaris (Roxb.)
Burttet Hill.) is one of the commonly used medicinal materials in Mongolian medicine,
which has the functions of activating qi and activating blood circulation, nourishing the heart and tranquilizing the mind. It is mainly used for qi stagnation and blood stasis, chest pain, palpitation, shortness of breath, and restlessness of mind. According to the preliminary statistics, there are 101 kinds of oral medicine containing Choerospondias
Axillaris Fructus. As an ancient prescription, Choerospondias Axillaris Fructus has been
recorded for a long time, and in 1990, the Chinese Pharmacopoeia began to record that it
was used as a medicine.
Choerospondias Axillaris (Roxb.) Burttet Hill., also known as South sour jujube, five
eye fruit or snot fruit, is a kind of tall deciduous tree belonging to the family
Anacardiaceae. At present, the Choerospondias Axillaris Fructus and its preparations
contained in whether in the national pharmacopoeia, or in the Inner Mongolia standard
medicine, refers to the dry mature fruit of Choerospondias Axillaris. Choerospondias
Axillaris Fructus, like other plant drugs, contains many chemical components, including
flavonoids, organic acids, sterols, volatile oils, coumarins, sugars, acidic components and
many kinds of amino acids, and it's main active component is flavonoids, that is Total
flavonoids of Choerospondias Axillaris Fructus. In that modem pharmacological
experimental study, Total flavonoids of Choerospondias Axillaris Fructus has obvious
effects of anti-arrhythmia, anti-anoxia and protection of myocardial ischemia, inhibition of
platelet aggregation and improvement of hemorheology, and can enhance the immune
function of mice.
The application of total flavonoids of Choerospondias Axillaris Fructus in medicine
field is very broad, and more and more prescriptions are developed and widely used. As the
medicinal value of the plant is further explored, it is bound to pose a new challenge to the
raw material demand of the medicinal material of Choerospondias Axillaris Fructus.
Therefore, it is very important and necessary to find substitutes and expand new medicinal
parts of it. In the early time, the folk developed the green tea, containing tea pigment and
made from wild leaves of Choerospondias Axillaris, which can reduce weight, reduce
blood pressure, enhance immunity and have the functions of antioxidation, anti-arrhythmia
if drunk often. Inspired by this and drawing lessons from the successful experience of
research and development of ginkgo biloba leaf, we conducted a comparative study on the
effective chemical components of the medicinal material (fruit) and leaves of
Choerospondias Axillaris and observed the pharmacological effects of the flavonoids
extracted from the leaves of Choerospondias Axillaris.
The leaf yield of Choerospondias Axillaris is sufficient, which is not limited by
seasons and years, If Choerospondias Axillaris Leaf can be used as Choerospondias
Axillaris Fructus or made into various pharmaceutical preparations, the medicinal value of
Choerospondias Axillaris will be promoted to a greater extent.
So far, there is no report on the chemical constituents and pharmacological effects of
the leaves of Choerospondias Axillaris.
SUMMARY
The object of the present invention is to develop and utilize the resources of the leaves
of Choerospondias Axillaris, which have been discarded as waste so far, especially the
development and utilization of flavonoid active ingredients therein.
Through the in-depth and detailed comparative study on the chemical components of
Choerospondias Axillaris Leaf and Choerospondias Axillaris Fructus (i.e. dry and mature
fruit), the invention firstly finds that the total flavonoids in the Choerospondias Axillaris
Leaf are more than those in Choerospondias Axillaris Fructus in type and content. In the
separated components, there are 13 in Choerospondias Axillaris Fructus and 15 in
Choerospondias Axillaris Leaf. In the Choerospondias Axillaris Fructus, there are
flavonoids such as anthocyanins, flavones, flavonols, dihydroflavones, chalcone,
isoflavones, and flavanols (catechins), etc. The flavonoids compounds in the leaves of
Choerospondias Axillaris include anthocyanins, flavones, flavonol, dihydroflavones,
dihydroflavonol, chalcone, isoflavone, flavanol, etc. On this basis, through a series of
comparison and reference experiments of Choerospondias Axillaris Fructus and
Choerospondias Axillaris Leaf, it is found that there are 6 corresponding common
components in the total flavonoids of both fructus and its Leaf. In term of that types of
flavonoid, they are: anthocyanin, dihydroflavone, flavonol, flavonol, chalcone, aurone.
The invention further discloses an extraction method of the flavonoid compounds and an
ideal silica gel thin layer chromatography separation system. In addition, it was found that
that total flavonoids of Choerospondias Axillaris Leaf had obvious effect of
anti-arrhythmia, protecting myocardial ischemia, improving immune function and
anti-oxidation. It can be used to replace Choerospondias Axillaris Fructus to prepare
products which can prevent and treat cardiovascular and cerebrovascular diseases, diseases
with reduced immune function and diseases related to free radical injury, including health
food and pharmaceutical compositions.
In this invention, the Choerospondias Axillaris Leaf is a leaf of the Choerospondias
Axillaris(Roxb.) Burttet Hill., belonging to Anacardiaceae plant; Total flavonoids refers
to the mixture of flavonoids extracted and separated from the leaves of Choerospondias
Axillaris (Roxb.) Burttet Hill.
BRIEF DESCRIPTION OF THE FIGURES
Figure 1 is the UV Vis absorption spectra of ethanol extracts from Choerospondias
Axillaris Fructus and Choerospondias Axillaris Leaf. The sample has the maximum
absorption value at 506nm.
Figure 2 is the standard curve of rutin reference substance.
Figure 3 is the TLC of alcohol solution of petroleum ether extraction of Choerospondias
Axillaris sample under the ultraviolet lamp (365 nm).
Figure 4 is the TLC of the sample after purification. The above-mentioned left picture is
the thin-layer developed spot observed under visible light, and the right picture is that
observed under ultraviolet lamp (365m).
a- Ethyl acetate extraction layer of ethanol extract from Choerospondias Axillaris Fructus
A-Extraction of water layer by ethyl acetate from ethanol extracts of Choerospondias
Axillaris Fructus
b- Ethyl acetate extraction layer of ethanol extract from Choerospondias Axillaris Leaf
B- Extraction of water layer by ethyl acetate from ethanol extracts of Choerospondias
Axillaris Leaf
Figure 5 is the TLC after purification of ethyl acetate extract on polyamide column.
a- Ethyl acetate extraction layer of ethanol extract from Choerospondias Axillaris Fructus
a'- Purified compounds of sample a on polyamide column
b- Ethyl acetate extraction layer of ethanol extract from Choerospondias Axillaris Leaf
b'- Purified compounds of sample b on polyamide column
S- quercetin
DESCRIPTION OF THE INVENTION
The present invention is accomplished by the following specific technical proposal,
The main contents include extraction, content determination, extraction identification,
separation and identification of flavonoids in fructus and leaves of Choerospondias
Axillaris; In that invention, the total flavonoids of Choerospondias Axillaris Leaf is used
for studying the effects of anti-arrhythmia, anti-immune function, myocardial ischemia
protection and anti-oxidation effect, and finally the invention is completed.
The main contents of this study are as follows: The extraction and determination of
flavonoids in Choerospondias Axillaris Fructus and Choerospondias Axillaris Leaf, the
identification of the extracts and the separation and identification of flavonoids.
In this experiment, the ethanol extracts of Choerospondias Axillaris Fructus and
Choerospondias Axillaris Leaf were extracted with petroleum ether, then extracted with
ethyl acetate and purified with polyamide column and the samples were developed on the
silica gel thin layer plate. More than 10~15 spots were observed under the ultraviolet lamp.
The color reaction was carried out by TLC, and different color spots appear on the
board, which showed there are many and complex kinds of total flavonoids in the leaves of
Choerospondias Axillaris and Choerospondias Axillaris Fructus. In combination with that
thin lay development of silica gel, the color development reaction on the TLC plate, and the
scraping absorption spectrum of each spot component substance under the
ultraviolet-visible spectrophotometry, 13 total flavonoid components of Choerospondias
Axillaris Fructus are finally identified, from the front to the bottom, they are: anthocyanin,
flavonol, flavone, anthocyanins, chalcone, dihydroflavone, flavonol, catechin, flavanol, chalcone, dihydroflavone, aurone and catechin; In Choerospondias Axillaris Leaf, there are flavonoid components, from the front to the bottom: anthocyanin, anthocyanin, anthocyanin, isoflavone, chalcone, anthocyanin, dihydroflavone, flavonol, flavonol, chalcone, chalcone, charlcone, aurone, aurone.
In that experiment, through many times of comparison, it was found that both of them
contain anthocyanin, flavone, flavonol, dihydroflavone, chalcone and aurone, etc.; by
silica gel TLC expansion method, TLC color development method, and UV Vis
spectrophotometry , The results showed that there were six spots of flavonoids in leaves of
Choerospondias Axillaris and Choerospondias Axillaris Fructus. From the leading edge to
the baseline, the sequence is: anthocyanin, dihydroflavone, flavonol, flavanol, chalcone,
aurone. The Rf values of spots 13'and 15 in the figure are the same, but the color reaction
shows that they are completely different chemical composition types.
In that experiment, the extraction and separation condition of the total flavonoid
components in Choerospondias Axillaris Leaf and Choerospondias Axillaris Fructus were
discussed, and an ideal silica gel thin layer chromatography separation system was found
out, which provides reliable information for the extraction, separation and identification of
the total flavonoids in Choerospondias Axillaris Leaf. At the same time, it provides
conditions for finding the corresponding components or substitutes in the leaves. The
specific process is as follows.
Pretreatment of Experimental Materials
Check whether the purchased or collected Choerospondias Axillaris Fructus and
Choerospondias Axillaris Leaf are moldy, rotten or moth-eaten under visible light, and
mash them separately after removing the residues, and keep them for future use.
Extraction of total flavonoids
Weigh 140 g of each of the above-treated Choerospondias Axillaris Fructus and
Choerospondias Axillaris Leaf, put them in a 2000 mL three-foot round-bottom flask
respectively, and perform reflux extraction with 8 times of 70% ethanol for 1.5 hours in
water bath heating, three times in parallel respectively. The extracted solutions were
collected, filtered to remove the residue, and then concentrated to a paste in a vacuum
rotary evaporator. Drying in oven at proper temperature to obtain solid paste and weighing
to obtain 14.20g and 40.40g of crude paste respectively, with the crude paste yield of
10.14% and 28.86% respectively.
Degreasing by extraction with petroleum ether
The dried extracts of Choerospondias Axillaris Fructus and Choerospondias Axillaris
Leaf were properly dissolved, and then petroleum ether is added for stirring extraction until
the ether layer of each extract has no color. Collect the solution of lower layer of petroleum
ether, concentrate and dry it, weigh it, and obtain 12.70 g and 33.39 g of dry paste
respectively after extracting fatty components from the leaves of Choerospondias Axillaris
and Choerospondias Axillaris Fructus and the paste yield of the two is 9.07% and 23.85%
respectively.
Quantitative test-standard curve method for quantitative determination of total flavonoids
Selection of the best absorption wavelength of flavonoids
It is necessary to determine the optimum wavelength for the quantitative
determination of flavonoids before the determination of total flavonoids by the standard
curve method. The method is as follows: Take the proper concentration of the above-mentioned extracted fructus solution (0.10 mg / mL), operate according to the standard curve. The sample has the maximum absorption value at 506nm, which is close to the optimum wavelength of 51Onm for rutin reference substance, as shown in Figure 1-1. In this experiment, the content of total flavonoids extracted from the leaves of
Choerospondias Axillaris and Choerospondias Axillaris Fructus was determined by
quantitative analysis method of general flavonoids, and rutin was used as control.
Preparation of standard curve
Accurately weigh 10.0mg of dry constant weight rutin reference substance, dilute
with 70% ethanol, dissolve thoroughly, and then fix the volume in a1OOmL volumetric
flask. Measure 0.OmL, 2.5mL, 5.OmL, 7.5mL, 10.OmL and 12.5mL of the
above-mentioned solutions respectively in a 25mL volumetric flask, and pipette 70%
ethanol solution make the volume to 12.5ml. Then, add 1.OmL of 5% NaNO2 solution
prepared fresh into each volumetric flask, shake it up, and stand it still for 6min; then add
1.0 mL of 10% Al (N03) 3 solution and shake up. After standing for 6min, add10.OmL of
4% NaOH solution, fix the volume with 70% ethanol solution to 25mL, shake up, and
stand for 12min. The reagent was used as a blank, and quantitative determination was
carried out at 51Onm. Regression equation: A = 12.125714 x C + 0.006524 r = 0.999795
(see Table 1-1). The resulting standard curve in shown at Figure 1-2.
Table 1-1 Concentration and absorbance of rutin reference substance
S/N 1 2 3 4 5 6 Concentration (mg/mL) 0.0000 0.0100 0.0200 0.0300 0.0400 0.0500 Absorbance A 0.000 0.134 0.256 0.374 0.489 0.611
Determination of the contents of the extracts of Choerospondias Axillaris Fructus and
Choerospondias Axillaris Leaf
Weigh 26.6mg and 11.2mg solid paste sample of Choerospondias Axillaris Fructus
and Choerospondias Axillaris Leaf accurately, put them into 100mL volumetric flasks
respectively, and dissolve them to a constant volume. Then put 2.5mL of the
above-mentioned sample solution into a 25mL volumetric flask and operate according to
the preparation method of the standard curve, measure the absorbance of the fructus A is
0.027, and the absorbance of the leaf A ' is 0.041, and substitute it into the regression
equation to calculate the total flavonoid content of the fructus and leaf of Choerospondias
Axillaris. (See Table 1-2).
Table 1-2 Content of Choerospondias Axillaris Samples
Concentration Ultraviolet Total flavonoids Total flavonoids Sample (mg / mL) absorbance content ofdry content(%.) cream(%o)
fructus 0.0017 0.027 6.39 0.580 leaf 0.0028 0.041 25.0 5.96 Note: Total flavonoid content of Choerospondias Axillaris Fructus = C * dilution multiple
/ sampling amount * paste yield. The content of total flavonoids in leaves of
Choerospondias Axillaris was calculated by the formula.
Identification of the extract
The conditions under which the total flavonoids are extracted are also suitable for the
extraction of alkaloids, polyphenols, and polysaccharide compounds, so that the identification must be carried out .Identification is carried out one by one according to the identification reaction specific to the above compounds.
Identification of polysaccharides
In that method, after the fatty components are extracted, the methanol solution of the
samples of Choerospondias Axillaris Fructus and Choerospondias Axillaris Leaf are taken
into a test tube respectively, and the freshly prepared Fehling's solution is added
respectively, and slightly heated for a while in a boiling water bath to observe the color
change of the test tube. Yellow to red-brown precipitation, positive reaction, shows that
there is polysaccharide.
Identification of alkaloids
Bismuth potassium iodide, mercuric potassium iodide and phosphotungstic acid were
added respectively to the test tubes containing three samples of methanol solution of
Choerospondias Axillaris Fructus and Choerospondias Axillarisye Leaf after extraction of
fatty components, and the color change of the solution was observed. Yellow to orange red
precipitation, which is added acid and not faded, showed positive reaction, and there are
alkaloids.
Identification of Polyphenols
FeCl3 methanol solution was used to react, after extraction of fatty components, 1.0
mL of methanol solution for Choerospondias Axillaris Fructus and 1.0 mL for
Choerospondias Axillaris Leaf were added with 2% FeCl3 respectively, and the color
change of the solution was observed. Yellow to dark green proved it is a positive reaction,
and there is polyphenol.
Identification of flavonoids
Referring documents (Chen Yegao, Plant Chemical Composition [M], Beijing:
Chemical Industry Publishing House, 2004: 3230), the above-mentioned prepared samples
methanol solutions were added with chromogenic reagents, respectively. Observe the
change phenomenon of each reaction (see Table 1-3), and the color reaction is positive.
Table 1-3 Color reaction of flavonoids
Main Sodium Zirconi Saturat Magnes Reactio Phosp HCl- Reactio Conce color (potassi um salt ed lead ium n with homol Mg n of 2% ntrated reacti um) reaction acetate acetate 2% ybdic powd alumin sulfuri on tetrahyd reaction reaction sodium acid er um c acid ride hydroxi reacti reacti trichlori reactio reaction de on on de n frutus No Yellow Yellow Orange Orange Blue- Red Bright Orange change precipit (bright) green purple yellow red ation leaf Magenta Yellow Yellow Orange Orange Green Red Yellow Dark precipit brown purple -green yellow ation
Separation and identification of flavonoids
Preliminary exploration of thin layer (TLC)
Self-made silica gel thin layer chromatography plate (10 x 20 cm 2); the spot sample is
the alcohol solution of Choerospondias Axillaris Fructus and Choerospondias Axillaris
Leaf after the extraction of fatty components by petroleum ether; developing agent:
Chloroform-ethyl acetate-methanol = 15: 20: 2. After the chromatographic plate was
sufficiently dried, 2% aluminum trichloride developer was sprayed, resulting in spots as shown in Figure 1-3 under the ultraviolet lamp (365 nm): The spots were few and there was tailing phenomenon, which had to be purified by ethyl acetate.
Extraction and Purification of Flavonoids from Choerospondias axillaris by Ethyl Acetate
In that invention, appropriate amount of Choerospondias Axillaris Fructus and
Choerospondias Axillaris Leaf ethyl acetate layer extract dry cream are dissolved in
methanol, and are respectively labeled as a and b to be used. The remaining insoluble
ethanol extract is dissolved in proper amount of water, and the water layer is evaporated to
dryness by extraction with ethyl acetate and dissolved in methanol. the fructus and leaf are
labeled as A and B respectively for standby.
Determination of total alkaloids
The samples a and b of Choerospondias Axillaris purified by ethyl acetate showed no
positive reaction in the alkaloid test; the water-soluble part had a positive reaction of
alkaloid (see Table 1-4).
Table 1-4 Alkaloids Detection
Number Bismuth iodide Mercuric iodidea Phosphotungstic Detection results acid fructus a Orange Red* Orange Orange None Orang RedBrown A OrangeRed Brown Precipitation Yes (Micro) Precipitate Precipitation
leaf b Orange Red Yellow Yellow None
B Orange red Yellow grey Orange Yes (Micro) precipitate precipitate
The purity of total flavonoids after purified by ethyl acetate is improved, and most
sugars, phenols and alkaloids have poor solubility in ethyl acetate and can be removed by
this method.
Identification of flavonoids
Combined with the identification experiment of flavonoids, preliminary identification
of the above-mentioned purified flavonoids of Choerospondias Axillaris Fructus and
Choerospondias Axillaris Leaf was done. The preliminary results of the identification
confirmed that both contain flavones, flavonols, dihydroflavones, anthocyanins, chalcones,
aurones, etc. (see Table 1-5).
Table 1-5 Identification of color reaction of flavonoids
Hydroc Hydroc Sodium Zirco Magnes Alkaline Phosp Sulfuric hloric hloric tetrahydr nium ium solution homol acid acid acid- oborate salt acetate ybdic -magne zinc acid sium powder powder Orange Fresh Yellow Green Orange Red Carmine Orange fructus red yellow brown Brown red result 3 4or5 123 123 3 1 12 2 2 or6 Purplish Purplish Fresh Green Light leaf rd ed Orange Orange Nn red red yellow Brown green result 123 123 3 1 12 12
Notes: 1. Flavone 2. Flavonol 3. Dihydroflavone 4. Anthocyanin 5. Chalcones 6. Aurone
References (Chen Xiaoquan. Botany Chemical Taxonomy [M]. Beijing: Higher
Education Press, 1990, 1:65) Take the above-mentioned purified extracts of
Choerospondias Axillaris Fructus and Choerospondias Axillaris Leaf samples with ethyl
acetate extract and insoluble alcohol extraction of the lower layer substance is made into
methanol solution and concentrated on the same self-made silica gel TLC plate, and then
sprayed with different color reagents for color reaction. Through observation and
comparison under visible light and ultraviolet light (365nm), according to the same sample
on the plate, different types of flavonoids can be identified by their respective color
development phenomena under the action of different reagents.
Thin layer development
On a self-made silica gel thin-layer chromatography plate (10x20 cm 2), use a
capillary tube to draw 10~20ul of the concentrated ethyl acetate extract for spotting, record
as a, b; Quercetin standard S; the same Spot the lower layer alcohol extracts A and B after
the ethyl acetate treatment on the same silica gel plate. Developing solvent: benzene-ethyl
acetate-methanol-formic acid=11:5:2:1. The separation points of the samples can be
clearly observed under visible light and ultraviolet light. Spray 2% aluminum trichloride
developer, observe the spots under visible light and ultraviolet light (365nm), record the
number of spots, color, size and Rf value as shown in Figure 1-4.
Separation and Purification of Total Flavonoids on Amide Column
In order to completely remove that polysaccharides, polyphenol and other impurities
of the paste extracted with ethyl acetate remaining in the above-mentioned frutus and leaf,
and to eliminate the interference of the late analysis of the impurities, a polyamide column
is applied to the paste, eluate with gradient ethanol, extract 10 ~ 70% ethanol eluate, combine and concentrate, and record as a ', b ' (Ref: Baiyune.Polyamide Separation of
Total Flavonoids of Trollius Chinensis [J] .Chinese Journal of Hospital Pharmacy. 2006;
26 (5): 514). Extract samples a b', a, b and quercetin standard sample S were conducted
thin layer chromatography. The above sample chromatographs are basically the same, and
the spots on the plate are compared with each other as shown in Figure 1-5.
According to the principle analysis of the separation and purification of total
flavonoids and other substances on polyamide column chromatography, the ethyl acetate
extract samples of Choerospondias Axillaris Fructus and Choerospondias Axillaris Leaf
were applied to polyamide column, and 10%~70% gradient concentration of ethanol was
collected and eluted. After evaporating to dryness and spotting on a silica gel thin-layer
plate, the developed spots are almost the same as those of the ethyl acetate extract. After
passing the column, the first-stage water eluent and gradient ethanol eluted, the column is
soaked in methanol, the above solution is concentrated and collected, and then the water
eluent, 10% to 70% gradient concentration ethanol eluent and colum soaking solution
with methanol were developed on the same thin-layer silica gel plate with a developing
agent (benzene-ethyl acetate-methanol-formic acid=11:5:2:1). Observation under
ultraviolet light showed that the spots of the water eluate were mainly concentrated at the
origin and did not expand, indicating that the component is relatively polar, and may
contain glycosides, or a small amount of flavonoid glycosides; 10% to 70% gradient
ethanol wash The deliquoring spots are separated well, which is almost the same as the
spots developed by the ethyl acetate extract; the spots separated by the methanol soaking
solution and the gradient ethanol eluate have corresponding spots, but there is a tongue-like
tailing phenomenon on the front. This comparative experiment shows that the content of impurities extracted by ethyl acetate is less, and it has little effect on the separation of fat-soluble flavonoids on silica thin-layer chromatography. This experiment will qualitatively identify the total flavonoids of fat-soluble organisms.
Color reaction on TLC expansion plate
Place the ethyl acetate extracts a , b, the quercetin standard S , the lower layer
insoluble alcohol extracts A and B on the self-made silica gel chromatography plate,. Use
the above condition of TLC to develop. The layers are unfolded, and then different color
reactions are performed on different plates, and the color development of each color
reaction (without color developer, spray 2% AlCl3, ammonia fumigation) under visible
light and ultraviolet light (365nm) is recorded.
TLC developed the color reaction on the plate, and initially identified the
corresponding points of the total flavonoids of Choerospondias Axillaris Fructus (1~13):
anthocyanins, flavonols, flavones, anthocyanins, chalcones, dihydroflavones, flavonols,
catechins, flavonols, chalcones, dihydroflavones, aurones, catechin; Choerospondias
Axillaris Leaf (1~15): anthocyanins, anthocyanins, anthocyanins, isoflavones, chalcones,
anthocyanins, dihydroflavones, flavonols, flavonols, chalcones, chalcones, chalcones,
aurones,aurones.
Qualitative identification of total flavonoids in Choerospondias Axillaris with thin-layer
scraper ultraviolet-visible spectrophotometer
Reference literature (Chen Yegao. Phytochemical components [M]. Beijing:
Chemical Industry Press, 2004, 3:235 ~ 237; Wu Lijun. Natural Medicine Chemistry [M].
Beijing: People's Medical Publishing House, 2005, 6: 190; Li Yunxia Et al.
Characterization of UV-Vis Absorption Spectroscopy of the Active Components of
Scutellaria baicalensis Georgi [J]. Spectroscopy and Spectral Analysis, 2007, 27(1): 131)
According to the UV spectrum characteristics of flavonoids (max/nm, methanol solution,
UV-Vis spectrophotometry), Scan the qualitative spectrum (190~600nm), and identify
the flavonoids based on the characteristic absorption peak spectrum of the scanned
flavonoids.
In the ultraviolet-visible spectrum, because the flavonoids have a cross-conjugated
system composed of cinnamoyl and benzoyl, there are two main ultraviolet absorption
bands at 200-400nm, band I (300-400nm) and band 11 (220 ~280nm). According to the
ultraviolet-visible spectrum characteristics of adding the diagnostic reagent AlCl3 to the
methanol solution and methanol solution, combined the flavonoids core structure and
substituent positions structural, it can infer the type of flavonoids.
Carefully scrape off the corresponding spots developed on the silica gel thin-layer
chromatography plates of Choerospondias Axillaris Fructus and Choerospondias Axillaris
Leaf, eluting with methanol, centrifugation, and take the clear liquid. In addition, scrape off
the blank part of the plate without sample as a blank component. Establish a baseline and
measure the ultraviolet-visible absorption spectrum.
The absorption spectra measured by ultraviolet-visible spectroscopy showed that the
spectra of Choerospondias Axillaris Fructus and Choerospondias Axillaris Leaf were the
same on the whole, except that the absorption peaks were different in strength and
displacement. Analyze the composition spectrum of the reference literature (Tan
Renxiang. Plant composition analysis [M]. Beijing: Science Press, 2002, 2: 496 ~ 500) to
determine the component type (see Table 1-6).
Table 1-6 UV Spectral Characteristics of Flavonoids (Xmax nm)
MeOH+AlCl3 Tpso MeOH solution Band shift value Typesof Control spot solution flavonoids Band I Band II Band I Band II BandI BandII detected Fructus 285 236 285 225 1 0 10 Anthocyanidins (Strong) (weak) (weak) (weak) 291 257 301 257 (weak) (weak) 10 0 Dihydroflavones 6 (Strong) (weak)
375 278 376 279 7 1 1 Flavonols (weak) (Strong) (weak) (Strong) 296 259 301 265 9 5 6 Flavonols (Strong) (Strong) (Strong) (Strong) 273 284 10 No No - 11 Chalcone (Strong) (Strong) 367 254 419 271 12 52 17 Aurones (Strong) (Strong) (Strong) (Strong) 285 236 287 2 No - 2 Anthocyanidins (Strong) (weak) (weak) 320 mid 277 335 277 (Strong) (Strong) 15 0 Dihydroflavones 8 (Strong) (Strong)
374 275 431 275 9 57 0 Flavonols (Strong) (Strong) (Strong) (Strong) Leaf 329 291 334 297 10 5 6 Flavonols (Strong) (Strong) (Strong) (Strong) 273 276 11 No No 0 3 Chalcone (Strong) (Strong) 325 278 375 289 14 50 11 Aurones (weak) (Strong) (weak) (Strong)
Note: The above is the UV spectrum (a-b) of the corresponding speckles of
Choerospondias Axillaris Fructus and Choerospondias Axillaris Leaf: 'and 2; 6' and 8; 7
'and 9; 9'and 10; 10 'and 11; 12' and 14.
Study on the pharmacological activity of the total flavonoids of Choerospondias Axillaris
Leaf
The effect of total flavonoids from leaves of Choerospondias Axillaris on arrhythmia
induced by aconitine in rats
Test Methods
There are 50 healthy Wistar rats, weighing 200g±20g. Randomly divided into 5
groups, each with 10 animals, half male and half female, respectively, the normal saline
control group, the total flavonoids group of Choerospondias Axillaris Fructus (0.2g/kg),
the high-dose group of total flavonoids of Choerospondias Axillaris Leaf (0.4g/kg), and
the middle-dose group of total flavonoids of Choerospondias Axillaris Leaf (0.2g/kg), and
the low-dose group of total flavonoids of Choerospondias Axillaris Leaf (0.1g/kg). Rats in
each group were administered intragastrically with a volume of 2ml/1OOg for 7 consecutive
days, lh after the last administration, intraperitoneal injection of 3% sodium pentobarbital
1ml/kg anesthetized, fixed supine, with BL-420F biological The functional experiment
system observes and records normal ECGII, then intravenously inject 10tg/ml aconitine
ig/kg, after 5 seconds, observe and record premature ventricular contractions
(ventricular premature) and ventricular tachycardia (ventricular tachycardia) within 30
minutes , Ventricular fibrillation (ventricular fibrillation), cardiac arrest (arrest) time.
Test results
Compared with the normal saline control group, the total flavonoids group of
Choerospondias Axillaris Fructus and the dosage group of total flavonoids of
Choerospondias Axillaris Leaf can significantly prolong the appearance of premature
beats, ventricular tachycardia, ventricular fibrillation and cardiac arrest in rats (see Table
2-1). The results suggest that total flavonoids of Choerospondias Axillaris Leaf are the
same as the total flavonoids of Choerospondias Axillaris Fructus, which has obvious
anti-arrhythmic effects.
Table 2-1 Effect of total flavones of Choerospondias Axillaris on occurrence time of
arrhythmia induced by aconitine in rats (z s,n=10)
Premature Ventricular Ventricular Cardiac Dose Group (g/kg) beat tachycardia fibrillation arrest (min) (min) (min) (min) Saline group - 2.20+0.28 19.38+1.97 23.38+1.81 15.92+1.51
Frutus group 0.2 8.18+1.55** 23.60+1.97** 25.60+0.66** 20.78+1.14**
High dose group of Leaf 0.4 9.08+1.84** 24.09+1.58** 27.08+1.89** 23.84+2.68**
Middle dose group of Leaf 0.2 8.46+1.47** 23.38+1.92** 25.70+2.01** 20.02+1.86**
Low dose group of Leaf 0.1 6.70+1.55** 21.40+1.69* 25.40+2.06* 17.26+1.03*
Compared with normal saline group, t test was performed, *P< 0.05, **P<0.01
The effect of total flavonoids of Choerospondias Axillaris Leaf on ischemic arrhythmia
caused by coronary artery ligation and the content of SOD and MDA in serum.
Test Methods
60 healthy Wistar rats, half male and half female, weighing 220±60g, were randomly
divided into 6 groups, each with 10 rats, namely the sham operation group (given normal
saline), the ischemia model group (given normal saline), Ischemic model+ total flavonoids
group of Choerospondias Axillaris Fructus (0.2g/kg), ischemia model+ total flavonoids of
Choerospondias Axillaris Leaf high-dose group (0.4g/kg), ischemia model + total
flavonoids of Choerospondias Axillaris Leaf middle-dose group (0.2g /kg), low-dose
group of total flavonoids of Choerospondias Axillaris Leaf (0.1g/kg). Rats in each group
were given intragastrically with a volume of 2ml/100g for 7 consecutive days. Ligate the
left anterior descending coronary artery 1 hour after the last administration, observe and
record the normal II lead ECG before thoracotomy and the occurrence and duration of
arrhythmia within 30 minutes of ischemia, the number of occurrences of ventricular
fibrillation; 5 hours after ischemia, blood is taken Prepare serum and measure the activity
of SOD and MDA according to the kit instructions; take out the heart after blood
collection, wash away residual blood with saline, and immediately put it in the refrigerator
to freeze. After the heart is frozen for 20 minutes in the refrigerator, cut the left ventricle
into 5 pieces of equal thickness from the apex of the heart to the direction parallel to the
atrioventricular sulcus. Place them in 1% TTC solution and stain them in a constant
temperature water bath at 37°C for 20 minutes to distinguish the necrotic area from
non-necrotic Another weighing, calculate the scope of myocardial infarction.
Test results
Compared with the ischemic model group, the total flavonoids of Choerospondias
Axillaris Fructus group and the total flavonoids of Choerospondias Axillaris Leaf in each
dose group can significantly prolong the appearance of arrhythmia caused by ligation of the coronary artery in rats, significantly reduce the number of ventricular abnormal beats, and continue ventricular tachycardia The time is significantly shortened, the incidence of ventricular fibrillation is significantly reduced, and the area of myocardial infarction is significantly reduced, the activity of SOD, an important oxygen free radical scavenger in the body, is significantly increased, and the content of MDA, a metabolite of lipid peroxidation, is significantly reduced (see Table 2-2. Table 2-3). The results suggest that the total flavonoids of Choerospondias Axillaris Leaf are the same as the total flavonoids of
Choerospondias Axillaris Fructus. It has obvious protective effect on myocardial ischemia
injury in rats, effectively resists arrhythmia caused by myocardial ischemia, and has
obvious antioxidant effect.
Table 2-2 Effect of Total Flavonoids of Choerospondias Axillaris Leaf on Arrhythmia
Induced by Coronary Artery Ligation(e*s,n=10)
Number of Sustained Occurrenc Dose Arrhythmia ventricular ventricular ventricular Group of appears (g/kg) extrasystole tachycardia fibrillation time(mi) (pieces) Time (min) Rate(%)
Sham operation group - 0.00±0.00 0+0 0.00+0.00 0
Ischemic model group - 5.57+1.35 961+337 2.30+0.59 90
Frutus group 0.2 8.35+3.52** 380+133** 1.55+0.88* 40**
High dose group of Leaf 0.4 10.773.57** 104+40** 1.100.99** 10**
Middle dose group of Leaf 0.2 8.59+4.38* 279+115** 1.40+0.97* 30*
Low dose group of Leaf 0.1 7.07+2.40 531+320** 1.60+0.52* 50*
Compared with ischemia model group, t test or X 2 test*p<0.05, **p<0.01
Table 2-3 Effects of total flavonoids of Choerospondias Axillaris Leaf on myocardial
infarction range and SOD andMDA contents in mice (z s,n=10)
Dose Myocardial MDA Group (g/kg) infarction SOD (U/mL) (nmol/mL) range (%) Sham operation group - 0.00±0.00 142.11+16.12 7.92±2.14
Ischemic model group - 27.089.70^^ 107.02+14.35^^ 15.27+2.28^^
Frutus group 0.2 17.23+6.33** 137.73+17.35** 11.22+2.11**
High dose group of Leaf 0.4 14.65+8.84** 138.62+19.86** 9.62+1.83**
Middle dose group of Leaf 0.2 17.55+5.77** 136.27+16.59** 10.88+2.54**
Low dose group of Leaf 0.1 18.94+5.90* 137.54+18.12** 12.39+2.07*
Compared with sham operation group, t-test ^^p<0.01;
Compared with the ischemia model group, t-test * p<0.05, **p<0.01
Effect of total flavonoids of Choerospondias Axillaris Leaf on immune function in mice
Test Methods
There were 150 healthy mice with 20 2g body weight. They were randomly
divided into 3 groups. Each group was further divided into 5 groups of 10 animals, half
male and half female, namely the normal saline control group, the total flavonoids group
of Choerospondias Axillaris Fructus (0.3g / kg), high-dose (0.6g / Kg) ,middle-dose (0.3g
/ kg) and low-dose groups (0.15g / kg) of total flavonoids of Choerospondias Axillaris
Leaf. In the first group, carbon clearance method was used to determine the effect of total
flavonoids extract of Choerospondias Axillaris Leaf on phagocytosis of monocyte macrophages referring to (Lu Yinjean, Pei Shaojun, Hu Xingju. "Purple Golden Propolis and Aloe Soft Capsule" on Immune Function of Mice, Chinese Journal of Health Testing,
2009. Nineteen (9): 1984-1985). The second group referring to (Xu Shuyun, Bian Rufu,
Chen Xiu, Pharmacological Experimental Methodology, People's Health Press, 2nd
Edition, 1984) adopts DTH method to measure the effects of each group on delayed-type
hypersensitivity (DTH) in mice. The Third Group of References is (Li Zhi, Chen Bifeng,
Huang Junming. the Effect of Ejiao Oral Liquid on Cellular Immunity and Humoral
Immunity in Mice, Chinese Journal of Health Inspection, 2008, 1196-1120). The effect of
each group on the production of hemolysin antibody induced by sheep red blood cells
(SRBC) in mice was measured by serum hemolytic method.
Test results
In comparison with that normal saline control group, the total flavonoids group of
Choerospondias Axillaris Fructus and the high and middle dosage groups of total
flavonoids of Choerospondias Axillaris Leaf significantly enhanced the phagocytic
function of monocyte macrophages in mice. The total flavonoids of Choerospondias
Axillaris Fructus group and the total flavonoids of Choerospondias Axillaris Leaf in each
dose group of the date palm could significantly enhance the delayed-type hypersensitivity
in mice. The production of hemolysin antibody in mice was significantly increased in the
total flavonoids group of Choerospondias Axillaris Fructus and the high and middle
dosage groups of total flavonoids of Choerospondias Axillaris Leaf, and the thymus index
of mice was increased significantly (Table 2-4, 2-5, and 2-6). The results showed that the
total flavonoids of Choerospondias Axillaris Leaf had the same effect as the total
flavonoids of Choerospondias Axillaris Fructus on enhancing cellular immunity, humoral immunity and nonspecific immunity.
Table 2-4 Effect of Total Flavonoids of Choerospondias Axillaris Leaf on
PhagocytosisofMonocyteMacrophage (Y±s, n=10)
Dose Phagocytic index Phagocytic Group (g/kg) K (10-') coefficient u
Saline group - 31.96±8.32 4.620±0.792
Frutus Group 0.3 41.31+5.88** 5.220+0.616**
High dose group of Leaf 0.6 42.71+7.04* 5.670+0.359**
Middle dose group of Leaf 0.3 43.41+9.52* 5.786+1.012*
Low dose group of Leaf 0.15 30.99±8.55 4.689±1.003
Compared with Saline group, t-test *p<0.05, **p<0.01
Table 2-5 Effect of Total Flavonoids of Choerospondias Axillaris Leaf on Delayed
Skin Hypersensitivity in Mice ( i±s, n=10)
Weight Dseif c Thymus Index Spleen index Dose difference Group (g/g body (g/g body (g/kg) between ears weight x 10) weight x 10) (mg) Saline group - 2.21+0.33 0.221+0.026 0.818+0.122
Frutus Group 0.3 3.48+0.21* 0.265+0.032* 0.922+0.033
High dose group of Leaf 0.6 4.15+1.90* 0.274+0.046* 1.000+0.111*
Middle dose group of Leaf 0.3 3.54+1.54* 0.202+0.141 0.942+0.419
Low dose group of Leaf 0.15 3.16+1.91* 0.206+0.113 0.806+0.668
Compared with Saline group, t-test*p<0.05, **p<0.01
Table 2-6 Effect of total flavonoids of Choerospondias Axillaris Leaf on hemolysin
antibody production in mice (x±s, n=10)
Spleen index Thymus Index Dose Hemolysin Group content (g/g body (g/g body (g/kg) (HC) weight x 10) weight x 10) Saline group - 301.833+31.775 0.861+0.268 0.238+0.052
Frutus Group 0.3 371.333+28.741** 0.847+0.121 0.326+0.031*
High dose group of Leaf 0.6 356.267+45.408* 0.793+0.114 0.511+0.201*
Middle dose group of Leaf 0.3 350.433+39.519* 0.894+0.246 0.390+0.112*
Low dose group of Leaf 0.15 300.767+65.707 1.037+0.274 0.304+0.133
Compared with Saline group, t-test *p<0.05, **p<0.01
Summary on Pharmacological Activities of Total Flavonoids of Choerospondias Axillaris
Leaf
The results of pharmacological activities of Total Flavonoids of Choerospondias
Axillaris Leaf showed that the total flavonoids in the leaves, like those from the fructus,
had obvious anti-arrhythmic effect, protective effect on myocardial ischemia injury,
obvious anti-oxidation effect and immune function enhancement effect. In that invention,
the Choerospondias Axillaris Leaf can replace the Choerospondias Axillaris Fructus to
extract the total flavonoids, and can be used to prepare products that can prevent and treat
cardiovascular and cerebrovascular diseases, diseases with reduced immune function and
diseases related to free radical injury, including health food and pharmaceutical
compositions.

Claims (11)

THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS:
1. The total flavonoids of Choerospondias Axillaris Leaf is characterized by being extracted
from the leaves of Choerospondias Axillaris, it contains one or more anthocyanins, flavones,
flavonol, dihydroflavones, dihydroflavonol, chalcone, isoflavone and flavanol.
2. The total flavonoids of Choerospondias Axillaris Leaf described in claim 1 is characterized in
that the content of total flavonoids is > 5.00%.
3. The preparation method of total flavonoids of Choerospondias Axillaris Leaf is characterized
in that the leaves are extracted with ethanol and separated by petroleum ether.
4. The ethanol described in claim 3 is characterized in that the concentration is 70% and the
dosage is 8 times of the intended extract.
5. The ethanol extraction described in claim 3 is characterized in that the water bath is heated at
85 °C and refluxed for 1.5h, and each extraction is carried out three times in parallel.
6. The petroleum ether extraction described in claim 3 is characterized in that the extract solution
is concentrated into a paste by a vacuum rotary evaporator, the paste extract is properly
dissolved, and then the petroleum ether is added for stirring extraction. The extraction is
repeated until the ether layer of each extract has no colour. The lower layer solution of
petroleum ether is collected and condensed and dried.
7. The preparation method of claim 3 is characterized in that it comprises further purification
steps of polyamide column separation or silica gel chromatography separation, after extraction
with ethyl acetate.
8. Claim 1 includes the use of the total flavonoids in the preparation of a product for the
prevention and treatment of cardiovascular and cerebrovascular diseases, diseases with
reduced immune function and diseases related to free radical injury.
9. The used of claim 8, wherein the diseases include arrhythmia, arteriosclerosis, coronary heart
disease, cerebral insufficiency, immune dysfunction, dementia, insomnia and amnesia, and
tumour.
10. Pharmaceutical compositions and preparations composed of total flavonoids of claim 1 and
other drugs and medically acceptable pharmaceutical excipients.
11. The preparation of claim 9 includes injection, tablet, capsule, film, pill, granule, oral liquid and
dropping pill.
-1/5-
Figure 1
-2/5-
Figure 2
-3/5-
Figure 3
-4/5-
Figure 4
-5/5-
Figure 5
AU2020101758A 2020-08-11 2020-08-11 Preparation Method and Application of Total Flavonoids of Choerospondias Axillaris Leaf Ceased AU2020101758A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2020101758A AU2020101758A4 (en) 2020-08-11 2020-08-11 Preparation Method and Application of Total Flavonoids of Choerospondias Axillaris Leaf

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2020101758A AU2020101758A4 (en) 2020-08-11 2020-08-11 Preparation Method and Application of Total Flavonoids of Choerospondias Axillaris Leaf

Publications (1)

Publication Number Publication Date
AU2020101758A4 true AU2020101758A4 (en) 2020-09-17

Family

ID=72432565

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020101758A Ceased AU2020101758A4 (en) 2020-08-11 2020-08-11 Preparation Method and Application of Total Flavonoids of Choerospondias Axillaris Leaf

Country Status (1)

Country Link
AU (1) AU2020101758A4 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115097058A (en) * 2022-06-24 2022-09-23 广西新桂环保科技集团有限公司 Thin-layer chromatography identification method for choerospondias axillaris

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115097058A (en) * 2022-06-24 2022-09-23 广西新桂环保科技集团有限公司 Thin-layer chromatography identification method for choerospondias axillaris
CN115097058B (en) * 2022-06-24 2023-08-04 广西新桂环保科技集团有限公司 Thin-layer chromatography identification method for Choerospondias axillaris

Similar Documents

Publication Publication Date Title
Xiao et al. Ethnopharmacologic study of Chinese rhubarb
AU2020278855A1 (en) Composition for increasing bioavailability and promoting absorption of ginsenosides in black ginseng extract
CN1292704A (en) Ginkgo leaves composition and preparation method and uses
Varadharajan et al. Physicochemical, phytochemical screening and profiling of secondary metabolites of Annona squamosa leaf extract
Zhang et al. Bioactive comparison of main components from unripe fruits of Rubus chingii Hu and identification of the effective component
Janarthanan et al. Physicochemical evaluation, Phytochemical screening and chromatographic fingerprint profile of Aegle marmelos (L.) leaf extracts
CN102749401B (en) Inspection method of traditional Chinese medicine composition twenty-five-ingredient lung disease preparation
Zhao et al. Chemical compositions, HPLC/MS fingerprinting profiles and radical scavenging properties of commercial Gynostemma pentaphyllum (Thunb.) Makino samples
Behlil et al. Phytochemical screening and antioxidant activity determination of some medicinally important plants of Balochistan
CN102160872A (en) Compound salvia dropping pill capsules
AU2020101758A4 (en) Preparation Method and Application of Total Flavonoids of Choerospondias Axillaris Leaf
CN101919979B (en) Detection method of traditional Chinese medicine composition for soothing liver-qi stagnation and tonifying spleen and removing dampness
Kianbakht et al. Antihypertensive efficacy and safety of Vaccinium arctostaphylos berry extract in overweight/obese hypertensive patients: A randomized, double-blind and placebo-controlled clinical trial
CN115951007B (en) Thin-layer chromatography detection method of Russian cherry formula particles
CN110376292A (en) A kind of ginseng extract reference substance, preparation method and applications
CN104490894A (en) Preparation method of spermacoce latifolia triterpenoids and application of spermacoce latifolia triterpenoid in preparation of glycosidase inhibitor medicine
Vashist et al. Pharmacognostical aspects of Glycyrrhiza glabra
CN109078047B (en) Preparation and application of effective part with tyrosinase inhibition effect in cortex mori
Syahputra et al. Antioxidant, Total Phenol, Total Flavonoid, and LC-MS/MS Analysis of Pometia Pinnata Ethanol Extract
CN102579527A (en) Fructus choerospondiatis leaf total flavone and extracting method and application thereof
KR100462788B1 (en) Composition containing an extract of pericarpium zanthoxyli for protecting brain cells and improving memory
CN100360551C (en) Acid-base process for preparing ursolic acid
CN111777657B (en) Saponin compound and preparation method and application thereof
Hikmawanti et al. The effect of different extracts of beetroots as antioxidant and anti-anaemia on phenylhydrazine-induced rats
CN1850195B (en) Detection method of medicine composition for treating chronic gastritis and gastric and duodenal ulcer

Legal Events

Date Code Title Description
FGI Letters patent sealed or granted (innovation patent)
MK22 Patent ceased section 143a(d), or expired - non payment of renewal fee or expiry